Neuroblastoma laboratory tests: Difference between revisions
Farima Kahe (talk | contribs) |
|||
(21 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Neuroblastoma}} | {{Neuroblastoma}} | ||
{{CMG}} {{AE}}{{HL}} | {{CMG}} {{AE}}{{ZAS}}{{HL}} | ||
==Overview== | ==Overview== | ||
laboratory findings of neuroblastoma include increased level [[ferritin]], [[catecholamine]], [[dopamine]], [[vanillylmandelic acid]] (VMA), [[homovanillic acid]] (HVA), [[lactate dehydrogenase]] and neuron-specific [[enolase]] levels. There are increased urinary [[catecholamine]], [[vanillylmandelic acid]] (VMA) and [[homovanillic acid]] (HVA) levels. | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
Laboratory findings consistent with the diagnosis of neuroblastoma include: <ref name="gov">Neuroblastoma Treatment for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq#link/_534_toc Accessed on October, 7 2015</ref><ref name="pmid21736987">{{cite journal| author=Colon NC, Chung DH| title=Neuroblastoma. | journal=Adv Pediatr | year= 2011 | volume= 58 | issue= 1 | pages= 297-311 | pmid=21736987 | doi=10.1016/j.yapd.2011.03.011 | pmc=PMC3668791 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21736987 }} </ref><ref>{{Cite journal | |||
==== | | author = [[Nadja C. Colon]] & [[Dai H. Chung]] | ||
* | | title = Neuroblastoma | ||
* | | journal = [[Advances in pediatrics]] | ||
* | | volume = 58 | ||
* | | issue = 1 | ||
* | | pages = 297–311 | ||
* | | year = 2011 | ||
* | | month = | ||
* | | doi = 10.1016/j.yapd.2011.03.011 | ||
| pmid = 21736987 | |||
}}</ref><ref>{{Cite journal | |||
* | | author = [[Sunghoon Kim]] & [[Dai H. Chung]] | ||
* | | title = Pediatric solid malignancies: neuroblastoma and Wilms' tumor | ||
* | | journal = [[The Surgical clinics of North America]] | ||
| volume = 86 | |||
| issue = 2 | |||
| pages = 469–487 | |||
| year = 2006 | |||
| month = April | |||
| doi = 10.1016/j.suc.2005.12.008 | |||
| pmid = 16580935 | |||
}}</ref><ref name="gov">Neuroblastoma Treatment for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq#link/_534_toc Accessed on October, 7 2015</ref><ref name="pmid21736987">{{cite journal| author=Colon NC, Chung DH| title=Neuroblastoma. | journal=Adv Pediatr | year= 2011 | volume= 58 | issue= 1 | pages= 297-311 | pmid=21736987 | doi=10.1016/j.yapd.2011.03.011 | pmc=PMC3668791 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21736987 }} </ref><ref>{{Cite journal | |||
| author = [[Andrew M. Davidoff]] | |||
| title = Neuroblastoma | |||
| journal = [[Seminars in pediatric surgery]] | |||
| volume = 21 | |||
| issue = 1 | |||
| pages = 2–14 | |||
| year = 2012 | |||
| month = February | |||
| doi = 10.1053/j.sempedsurg.2011.10.009 | |||
| pmid = 22248965 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[M. S. Blois]] & [[P. W. Banda]] | |||
| title = Letter: Laboratory diagnosis of neuroblastoma | |||
| journal = [[The New England journal of medicine]] | |||
| volume = 295 | |||
| issue = 16 | |||
| pages = 899–900 | |||
| year = 1976 | |||
| month = October | |||
| doi = 10.1056/NEJM197610142951617 | |||
| pmid = 958297 | |||
}}</ref> | |||
*Blood tests | |||
**Decreased [[hemoglobin]] | |||
**Increased [[ferritin]] | |||
**Increased [[catecholamine]] | |||
**Increased [[dopamine]] | |||
**Increased [[vanillylmandelic acid]] (VMA) | |||
**Increased [[homovanillic acid]] (HVA) | |||
**Increased [[lactate dehydrogenase]] (>1500 U/ml) | |||
**Increased neuron-specific [[enolase]] (>100 ng/ml) | |||
*Urine analysis | |||
**Increased [[catecholamine]] | |||
**Increased [[vanillylmandelic acid]] (VMA) | |||
**Increased [[homovanillic acid]] (HVA) | |||
==References== | ==References== | ||
Line 31: | Line 74: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] |
Latest revision as of 15:32, 6 March 2019
Neuroblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neuroblastoma laboratory tests On the Web |
American Roentgen Ray Society Images of Neuroblastoma laboratory tests |
Risk calculators and risk factors for Neuroblastoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]Haytham Allaham, M.D. [3]
Overview
laboratory findings of neuroblastoma include increased level ferritin, catecholamine, dopamine, vanillylmandelic acid (VMA), homovanillic acid (HVA), lactate dehydrogenase and neuron-specific enolase levels. There are increased urinary catecholamine, vanillylmandelic acid (VMA) and homovanillic acid (HVA) levels.
Laboratory Findings
Laboratory findings consistent with the diagnosis of neuroblastoma include: [1][2][3][4][1][2][5][6]
- Blood tests
- Decreased hemoglobin
- Increased ferritin
- Increased catecholamine
- Increased dopamine
- Increased vanillylmandelic acid (VMA)
- Increased homovanillic acid (HVA)
- Increased lactate dehydrogenase (>1500 U/ml)
- Increased neuron-specific enolase (>100 ng/ml)
- Urine analysis
- Increased catecholamine
- Increased vanillylmandelic acid (VMA)
- Increased homovanillic acid (HVA)
References
- ↑ 1.0 1.1 Neuroblastoma Treatment for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq#link/_534_toc Accessed on October, 7 2015
- ↑ 2.0 2.1 Colon NC, Chung DH (2011). "Neuroblastoma". Adv Pediatr. 58 (1): 297–311. doi:10.1016/j.yapd.2011.03.011. PMC 3668791. PMID 21736987.
- ↑ Nadja C. Colon & Dai H. Chung (2011). "Neuroblastoma". Advances in pediatrics. 58 (1): 297–311. doi:10.1016/j.yapd.2011.03.011. PMID 21736987.
- ↑ Sunghoon Kim & Dai H. Chung (2006). "Pediatric solid malignancies: neuroblastoma and Wilms' tumor". The Surgical clinics of North America. 86 (2): 469–487. doi:10.1016/j.suc.2005.12.008. PMID 16580935. Unknown parameter
|month=
ignored (help) - ↑ Andrew M. Davidoff (2012). "Neuroblastoma". Seminars in pediatric surgery. 21 (1): 2–14. doi:10.1053/j.sempedsurg.2011.10.009. PMID 22248965. Unknown parameter
|month=
ignored (help) - ↑ M. S. Blois & P. W. Banda (1976). "Letter: Laboratory diagnosis of neuroblastoma". The New England journal of medicine. 295 (16): 899–900. doi:10.1056/NEJM197610142951617. PMID 958297. Unknown parameter
|month=
ignored (help)